Barclays PLC — Director's Dealing 2018

Aug 28, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

FORM 8.3 - TAKEDA PHARMACEUTICAL CO LTD

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)		Full name of discloser:		Barclays PLC.
(b)		Owner or controller of interest and short
		positions disclosed, if different from 1(a):
(c)		Name of offeror/offeree in relation to whose		TAKEDA PHARMACEUTICAL CO LTD
		relevant securities this form relates:
(d)		If an exempt fund manager connected with an
		offeror/offeree, state this and specify identity of
		offeror/offeree:
(e)		Date position held/dealing undertaken:		27 August 2018
(f)		In addition to the company in 1(c) above, is the discloser making		YES:
		disclosures in respect of any other party to the offer?		SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:				Ordinary NPV
				Interests				Short Positions
				Number		(%)		Number		(%)
(1)		Relevant securities owned
		and/or controlled:		11,467,341		1.44%		12,550,723		1.58%
(2)		Cash-settled derivatives:
				18,482,790		2.33%		17,060,300		2.15%
(3)		Stock-settled derivatives (including options)
		and agreements to purchase/sell:		16,823,700		2.12%		17,243,700		2.17%
		TOTAL:		46,773,831		5.89%		46,854,723		5.90%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
ADR		Purchase		13,108		21.1765 USD
ADR		Purchase		25,170		21.1419 USD
ADR		Purchase		26,068		21.1842 USD
ADR		Purchase		39,474		21.1800 USD
ADR		Purchase		45,849		21.1762 USD
ADR		Sale		6,375		21.1527 USD
ADR		Sale		26,068		21.1842 USD
ADR		Sale		39,474		21.1800 USD
ADR		Sale		50,340		21.1610 USD
Ordinary NPV		Purchase		100		4,635.0000 JPY
Ordinary NPV		Purchase		400		4,652.0000 JPY
Ordinary NPV		Purchase		800		4,649.6250 JPY
Ordinary NPV		Purchase		900		4,649.7777 JPY
Ordinary NPV		Purchase		1,100		4,642.0909 JPY
Ordinary NPV		Purchase		1,400		4,652.3928 JPY
Ordinary NPV		Purchase		1,500		4,635.6000 JPY
Ordinary NPV		Purchase		1,700		4,651.0000 JPY
Ordinary NPV		Purchase		1,900		4,647.0526 JPY
Ordinary NPV		Purchase		1,900		4,650.2631 JPY
Ordinary NPV		Purchase		2,100		4,650.4000 JPY
Ordinary NPV		Purchase		2,500		4,642.2400 JPY
Ordinary NPV		Purchase		2,500		4,651.7600 JPY
Ordinary NPV		Purchase		3,400		4,651.9000 JPY
Ordinary NPV		Purchase		3,800		4,650.1842 JPY
Ordinary NPV		Purchase		4,700		4,648.9893 JPY
Ordinary NPV		Purchase		6,900		4,650.9565 JPY
Ordinary NPV		Purchase		8,400		4,650.0000 JPY
Ordinary NPV		Purchase		9,500		4,651.8842 JPY
Ordinary NPV		Purchase		14,700		4,652.3197 JPY
Ordinary NPV		Purchase		19,600		4,646.9081 JPY
Ordinary NPV		Purchase		40,600		4,651.5862 JPY
Ordinary NPV		Purchase		47,100		4,646.2696 JPY
Ordinary NPV		Purchase		116,600		4,646.6432 JPY
Ordinary NPV		Purchase		180,900		4,644.3598 JPY
Ordinary NPV		Purchase		3,200,000		4,651.0581 JPY
Ordinary NPV		Sale		100		4,620.0000 JPY
Ordinary NPV		Sale		100		4,651.0400 JPY
Ordinary NPV		Sale		148		4,655.5405 JPY
Ordinary NPV		Sale		148		4,650.5405 JPY
Ordinary NPV		Sale		341		4,644.2697 JPY
Ordinary NPV		Sale		397		4,647.0604 JPY
Ordinary NPV		Sale		1,000		4,650.3000 JPY
Ordinary NPV		Sale		1,100		4,652.0000 JPY
Ordinary NPV		Sale		1,100		4,642.0909 JPY
Ordinary NPV		Sale		1,400		4,652.3928 JPY
Ordinary NPV		Sale		1,400		4,619.0000 JPY
Ordinary NPV		Sale		1,409		4,652.0617 JPY
Ordinary NPV		Sale		1,500		4,635.6000 JPY
Ordinary NPV		Sale		1,900		4,647.0526 JPY
Ordinary NPV		Sale		2,500		4,643.0800 JPY
Ordinary NPV		Sale		2,700		4,652.9629 JPY
Ordinary NPV		Sale		3,072		4,655.2752 JPY
Ordinary NPV		Sale		3,600		4,649.8333 JPY
Ordinary NPV		Sale		4,500		4,651.5333 JPY
Ordinary NPV		Sale		4,600		4,650.0869 JPY
Ordinary NPV		Sale		4,700		4,648.9893 JPY
Ordinary NPV		Sale		5,300		4,650.8301 JPY
Ordinary NPV		Sale		5,400		4,650.5000 JPY
Ordinary NPV		Sale		6,400		4,648.0000 JPY
Ordinary NPV		Sale		6,500		4,650.0000 JPY
Ordinary NPV		Sale		7,485		4,651.2398 JPY
Ordinary NPV		Sale		8,800		4,627.0909 JPY
Ordinary NPV		Sale		19,600		4,646.2040 JPY
Ordinary NPV		Sale		120,400		4,646.5008 JPY
Ordinary NPV		Sale		304,700		4,648.4686 JPY
Ordinary NPV		Sale		3,200,600		4,651.0000 JPY

(b) Cash-settled derivative transactions

Class of		Product		Nature of dealing		Number of		Price per
relevant		description				reference		unit
security						securities
Ordinary NPV		SWAP		Long		100		4,651.0348 JPY
Ordinary NPV		SWAP		Long		121		4,655.0344 JPY
Ordinary NPV		SWAP		Long		148		4,650.5349 JPY
Ordinary NPV		SWAP		Long		148		4,655.5344 JPY
Ordinary NPV		SWAP		Long		184		4,644.7746 JPY
Ordinary NPV		SWAP		Long		213		4,649.0350 JPY
Ordinary NPV		SWAP		Long		220		4,638.3452 JPY
Ordinary NPV		SWAP		Long		619		4,648.2926 JPY
Ordinary NPV		SWAP		Long		790		4,655.0152 JPY
Ordinary NPV		SWAP		Long		1,278		4,652.7792 JPY
Ordinary NPV		SWAP		Long		1,794		4,657.0530 JPY
Ordinary NPV		SWAP		Long		3,046		4,650.2609 JPY
Ordinary NPV		SWAP		Long		4,439		4,651.9114 JPY
Ordinary NPV		SWAP		Short		500		4,651.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security		Product description e.g. call option		Writing, purchasing, selling, varying etc.		Number of securities to which option relates		Exercise price per unit		Type e.g. American, European etc.		Expiry date		Option money paid/ received per unit

(ii) Exercise

Class of relevant security		Product description e.g. call option		Exercising/ exercised against		Number of securities		Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security		Nature of dealing e.g. subscription, conversion		Details		Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?		YES
Date of disclosure:		28 Aug 2018
Contact name:		Large Holdings Regulatory Operations
Telephone number:		020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings		Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose		TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class		Product		Writing,		Number		Exercise		Type		Expiry
of		description		purchasing,		of		price				date
relevant				selling,		securities		per unit
security				varying etc		to which
						option
						relates
Ordinary NPV		Call Options		Purchased		39,000		5781.0000		European		14 Dec 2018
Ordinary NPV		Call Options		Purchased		40,000		6182.0000		European		14 Dec 2018
Ordinary NPV		Call Options		Purchased		48,000		4625.0000		European		12 Oct 2018
Ordinary NPV		Call Options		Written		-460,000		6182.0000		European		14 Dec 2018
Ordinary NPV		Call Options		Written		-114,000		4750.0200		European		14 May 2019
Ordinary NPV		Call Options		Written		-104,700		5065.8300		European		17 Apr 2019
Ordinary NPV		Call Options		Written		-78,000		5781.0000		European		14 Dec 2018
Ordinary NPV		Put Options		Purchased		-48,000		4625.0000		European		12 Oct 2018
Ordinary NPV		Put Options		Purchased		-39,000		5781.0000		European		14 Dec 2018
Ordinary NPV		Put Options		Written		78,000		5781.0000		European		14 Dec 2018
Ordinary NPV		Put Options		Written		104,700		5065.8300		European		17 Apr 2019
Ordinary NPV		Put Options		Written		114,000		4750.0200		European		14 May 2019
Ordinary NPV		Call Options		Purchased		3,200,000		4651.0142		European		5 Sep 2018
Ordinary NPV		Call Options		Purchased		13,200,000		4799.0427		European		5 Sep 2018
Ordinary NPV		Call Options		Written		-13,200,000		4799.0427		European		5 Sep 2018
Ordinary NPV		Call Options		Written		-3,200,000		4651.0142		European		5 Sep 2018
Ordinary NPV		Put Options		Purchased		-13,200,000		4799.0427		European		5 Sep 2018
Ordinary NPV		Put Options		Purchased		-3,200,000		4651.0142		European		5 Sep 2018
Ordinary NPV		Put Options		Written		3,200,000		4651.0142		European		5 Sep 2018
Ordinary NPV		Put Options		Written		13,200,000		4799.0427		European		5 Sep 2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

BARCLAYS PLC

View source version on businesswire.com: https://www.businesswire.com/news/home/20180828005542/en/